Answering Your Frequently Asked Questions
The 8th CNS Drug Delivery Summit is the leading industry meeting dedicated to advancing technologies that improve drug delivery to the central nervous system (CNS). Bringing together 100+ leaders from pharma, biotech, academia and investment, the event explores the latest innovations in BBB shuttles, oligonucleotide delivery, gene therapies, biologics, focused ultrasound and direct CNS delivery strategies.
Designed for cross-functional CNS teams, the summit focuses on overcoming the scientific and translational challenges of achieving safe, effective and scalable brain delivery.
The conference will take place in Boston, Massachusetts, at the Hyatt Regency Boston Harbor, located at 101 Harborside Drive, Boston, MA 02128.
As a global hub for biotech and pharmaceutical innovation, Boston provides the ideal setting for collaboration, networking and knowledge exchange among CNS drug development leaders.
You'll meet a highly technical, cross-functional audience including CNS biologists, neuroscientists, drug delivery experts, DMPK and translational scientists, protein engineers, gene therapy specialists, business development leaders, investors and technology providers.
Attending and speaking organizations include Roche, AbbVie, Eli Lilly, Novartis, Lundbeck, Biogen, Alnylam Pharmaceuticals, JCR Pharmaceuticals, Voyager Therapeutics, UCB, Stoke Therapeutics, Daiichi Sankyo and many more.
The agenda spans the full CNS drug delivery landscape, with key themes including:
- Next-generation BBB shuttles and receptor-mediated transport technologies
- Biodistribution, imaging and quantifying CNS exposure
- Antibody, oligonucleotide and gene therapy delivery strategies
- Direct-to-brain delivery, intrathecal administration and focused ultrasound
- Dose scaling, translational modelling and PK/PD approaches
- Novel capsid and vector engineering for CNS applications
- Clinical translation, safety and toxicology considerations
- Investment, partnership and commercialization trends in CNS delivery technologies
Unlike broader neuroscience meetings, this summit is focused exclusively on CNS drug delivery and brain access technologies. It brings together experts across biology, drug delivery, DMPK, translational science, protein engineering and platform development to address the industry's most pressing delivery challenges.
With dedicated Technology & Platform Development and Biology & Implementation tracks, attendees can tailor their experience to the topics most relevant to their role and research priorities.
As a delegate, you will:
- Learn how leading organizations are advancing BBB-crossing technologies
- Gain insights into the latest developments in biologics, oligonucleotides and gene therapies
- Discover new approaches to measuring and optimizing CNS exposure
- Benchmark strategies with peers across pharma, biotech and academia
- Build relationships with key decision-makers and technology innovators
- Leave with practical takeaways to accelerate your CNS delivery programs
You can register directly through the official summit website. Multiple pass options are available, including full-access and conference-only passes for drug developers, academics and solution providers. Early booking discounts are available for qualifying registrations.
Partnering with the CNS Drug Delivery Summit gives you direct access to senior decision-makers actively evaluating technologies, services and partnerships to accelerate CNS therapeutic development.
Sponsorship opportunities allow you to showcase your expertise, generate new business opportunities, increase brand visibility and position your organization as a trusted partner within the CNS drug delivery community.
The summit takes place from December 1-3, 2026 in Boston, Massachusetts.
Pre-Conference Day (December 1):
- Focused Ultrasound vs Brain Shuttles: Comparing Clinical Scalability for BBB Penetration
- Integrating Systemic & Direct Delivery Approaches: Breaking Down the Silos
Conference Days (December 2-3):
- Technology & Platform Development Track
- Biology & Implementation Track
- Keynotes, technical presentations, panel discussions and case studies
- Scientific poster sessions and networking opportunities
Do You Offer Group Discounts?
Yes. Group discounts are available for organizations registering multiple delegates.
Discounts apply when two or more delegates from the same company register and pay at the same time. Savings increase for larger groups, with discounts available for 2, 3 and 4+ passes.
Yes. Discounted academic rates are available for eligible academic and research attendees. Bookings are subject to approval and attendees should select the appropriate pricing category when registering.
For questions about registration, attendance, speaking opportunities or pricing:
Email: info@hansonwade.com
For sponsorship and partnership enquiries:
Email: sponsor@hansonwade.com
The team will be happy to assist with any questions relating to attendance, registration or partnership opportunities.
Explore the Agenda
Dive into 2 tracks, spanning discovery – clinical development and access, 3 preconference day workshops and 25+ expert speakers shaping the future of CNS drug delivery.
Partner With Us
Showcase your solutions, connect with decision makers, and position your company as the go-to provider to CNS drug developers focused on brain delivery.
Join Biopharma Experts
Network with pharma, biotech, diagnostics, academia, consortia, and regulatory voices driving real-world adoption.